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Introduction  
Myocardial perfusion imaging (MPI) with positron emission tomography (PET)/computed 
tomography (CT) is an accurate noninvasive procedure for the management of patients with 
suspected and known coronary artery disease (CAD), allowing an accurate quantitative 
measurements of coronary artery calcium (CAC), myocardial blood flow (MBF) and 
myocardial perfusion in one examination [1-3]. PET is currently the most validated imaging 
technique for the absolute quantitative evaluation of MBF and coronary flow reserve (CFR). 
Despite the diagnosis of obstructive CAD by MPI procedures is typically achieved by 
quantitative assessment of myocardial ischemia, evaluated as relative hypoperfusion between 
stress and rest images, consistent data demonstrated that CFR provides additional diagnostic 
power in detecting CAD, especially in the assessment of multivessels disease [4,5]. A normal 
CFR has been demonstrated to have a high negative predictive value for excluding high-risk 
CAD on angiography [6]. As well, an abnormal CFR increases the probability to identify 
significant obstructive CAD. Considering that the use of CAC scanning before or combining 
it with PET-MPI could lead to a change in the clinical management of patients without known 
CAD [7], the full understanding in combining functional and anatomic data by PET/CT is of 
great clinical interest. Recently, a combination of regional ischemic total perfusion deficit 
(ITPD) along with regional and global CAC scores has been demonstrated to enhance the 
overall diagnostic accuracy of PET/CT in the detection of obstructive CAD [8]. However, no 
data are available on the role of regional CFR in combining functional and anatomic imaging. 
Thus, aim of the present investigation was to examine the full interaction between regional 
CAC score, myocardial ischemia and quantitative CFR in the identification of obstructive 
CAD.  
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Materials and method  
Study population 
We evaluated 388 consecutive patients with suspected or known CAD, referred to PET/CT 
MBF measurements between March 2014 and June 2016. Patients (n=134) have been 
excluded for: 1) prior myocardial revascularization procedures; (2) recurrent chest pain 
unresponsive to anti-ischemic medications; (3) recent acute coronary syndrome, stroke, or 
transient ischemic attack (past 3 months); (4) uncompensated congestive heart failure (New 
York Heart Association class III or IV) or recent admission for uncompensated heart failure 
(in the last 3 months); (5) pacemaker or prosthetic valve; (6) an absolute contraindication to 
dipyridamole, defined as ongoing wheezing, greater than first-degree atrioventricular block 
without a pacemaker, systolic blood pressure lower than 90 mm Hg, or recent (24 hours) use 
of dipyridamole or xanthines (eg, aminophylline and caffeine); (7) premenopausal women, 
unless it could be documented that they were not pregnant or lactating, and any patients 
unable to provide signed informed consent.  Of the remaining 254 patients, 93 were referred 
to coronary angiography after 6 months by referring clinical physician and were considered 
for the analysis. For each patient the presence of coronary risk factors was noted. 
Hypertension was defined as a blood pressure ≥140/90 mmHg or the use of anti-hypertensive 
medication. Hypercholesterolemia was defined as total cholesterol level >6.2 mmol/L or 
treatment with cholesterol lowering medication. Patients were classified as having diabetes if 
they were receiving treatment with oral hypoglycemic drugs or insulin. A positive family 
history of CAD was defined by the presence of disease in first-degree relatives younger than 
55 years in men or 65 years in women.  
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PET/CT imaging 
As a routine preparation for 82Rb cardiac PET/CT, patients were asked to discontinue taking 
nitrates for 6 hours, calcium channel blockers and caffeine-containing beverages for 24 hours, 
and b-blockers for 48 hours before their appointment. Scans were acquired using a Discovery 
LS scanner (GE). Rest and stress cardiac PET/CT images were acquired as follows: following a CT 
scout acquisition (120 kVp, 10 mA) for proper patient positioning, a CT transmission scan 
was acquired (140 kVp, 80 mA) for subsequent attenuation correction and for CAC score 
measurements. Rest and stress CT transmission scans were acquired at end-expiration breath-
hold, and patients were instructed to breathe normally during the PET acquisition. For both 
rest and stress images 1110 MBq of 82Rb were injected intravenously and a 6-minute 
dynamic PET study (12x8 seconds, 5x12 seconds, 1x30 seconds, 1x60 seconds and 1x60 
seconds) was acquired. Pharmacologic stress was then administered using dipyridamole 
(0.142 mg/kg/min for 4 minutes). Both rest and stress dynamic images were reconstructed 
using attenuation-weighted ordered-subset expectation maximization (21 subsets and 2 
iterations). CT-based attenuation, scatter, including decay and random corrections were 
applied to the reconstructed images. The heart rate, systemic blood pressure, and 12-lead ECG 
were recorded at baseline and throughout the infusion of dipyridamole. The rate pressure 
product was calculated as heart rate multiplied by systolic blood pressure. 
CT data analysis 
For CAC scoring measurements, rest CT axial reconstructions were transferred to a dedicated 
workstation (Vitrea Workstation, Toshiba Medical Systems, Tokyio, JAPAN) for post-
processing and subsequent analysis. Coronary calcification was defined as a plaque with an 
area of 1.03 mm2 and a density ≥130 HU. The CAC score was calculated according to the method 
described by Agatston [9].  Experienced nuclear medicine physicians analyzed the CT, blinded 
to the PET results. CAC scores values were calculated separately for left anterior descending 
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(LAD), left circumflex (LCx), and right (RCA) coronary arteries. CAC score was also 
categorized into 2 groups, <300 and ≥300 [10]. 
Perfusion data analysis 
Transaxial PET perfusion images were automatically reoriented into short-axis and vertical 
and horizontal long-axis slices using dedicated software (Emory Cardiac Toolbox, version 
3.05, Emory University Medical Centre, Atlanta, GA). Myocardial perfusion was evaluating 
according to the 17-segment American Heart Association model [11]. Total perfusion defect 
(TPD) reflecting a combination of both severity and extent of myocardial defect was 
calculated using automated software (Cedars-Sinai Medical Center, Los Angeles, California) 
[12]. Per-vessel ischemic TPD (ITPD) was defined as stress TPD ─ rest TPD and computed 
separately for each vascular territory: left anterior descending (LAD), left circumflex (LCX) 
and right coronary artery (RCA). IPTD values were categorized into three groups (0%; <5%; 
≥5%) [8]. Absolute MBF (in mL·min-1·g-1) was computed from the dynamic rest and stress 
imaging series with commercially available software (FlowQuant, University of Ottawa Heart 
Institute) [13]. In addition, regional MBF was calculated for each of three vascular territories. 
Global and regional CFR was defined as the ratio of hyperemic to baseline MBF. 
Invasive Coronary Angiography 
Coronary angiography was performed using the standard Judkins method [14]. Experienced 
cardiologists visually interpreted all coronary angiograms. Presence of luminal diameter 
stenosis ≥75% in at least one of the three vascular territories (LAD, LCx and RCA) was 
considered as obstructive CAD [8].  
Statistical Analysis 
Continuous data are expressed as mean ± standard deviation and categorical data as 
percentage. A student two-sample t-test and chi-square test were used to compare the 
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differences in continuous and categorical variables, respectively. A P value <0.05 (two-sided) 
was considered statistically significant. Univariable receiver operating characteristic (ROC) 
curves, were constructed to obtain the best trade-off between sensitivity and specificity for 
different cutoff points of regional CFR in identifying obstructive CAD. Univariable and 
multivariable logistic regression analyses were used to evaluate the variables associated with 
obstructive CAD. The incremental value of different models was assessed: model 1 
considered clinical data and CAC score, model 2 considered model 1 and ITPD categories and 
model 3 considered model 2 and CFR. Finally, the continuous net reclassification 
improvement (NRI), using the formula proposed by Pencina et al. [15], was used to evaluate 
CFR was additive upon clinical data, CAC score and regional ITPD in the prediction 
obstructive CAD. Statistical analysis was performed with Stata 12 software (StataCorp, 
College Station, Texas USA).  
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Results 
Patient characteristics 
Coronary angiography showed obstructive CAD in 36 (39%) patients and non-obstructive 
CAD in 57 (61%) patients. In particular, 23 (64%) patients had single vessels disease, 8 
(22%) two vessels disease and 5 (14%) patients tree vessels disease. Baseline characteristics 
of patient population according to the presence of obstructive CAD are shown in Table 1. 
Patients with obstructive CAD were older with a higher prevalence of male gender. 
Myocardial perfusion findings in per vessels analysis 
Of the overall 279 vessels analyzed, obstructive CAD was observed in 54 (19%) vessels and 
non-obstructive CAD in 225 (81%) vessels. Coronary calcium and myocardial perfusion 
findings according to the presence of obstructive CAD in per-vessels analysis are illustrated in 
Table 2. During dipyridamole-induced hyperemia, baseline MBF increased significantly both 
in vessels with and without obstructive CAD (P<0.001 hyperemia vs baseline). As reported, 
the vessels with obstructive CAD showed a higher CAC score and a significantly lower 
baseline MBF, hyperemic MBF and CFR (P<0.005) and a higher ITPD (P<0.001) compared 
to vessels without obstructive CAD.  
Prevalence of ITPD according to CAC score categories 
ITPD was 0% in 174 (63%), <5% in 79 (28%) and ≥5% in 26 (9%) vessels. Of the 244 
vessels with a CAC score <300, ITPD was 0% in 159 (65%), <5% in 63 (26%) and ≥5% in 22 
(9%) vessels. In the 35 vessels with CAC score ≥300, ITPD was 0% in 15 (43%), <5% in 16 
(46%) and ≥5% in 4 (11%) vessels (Figure 1). As observed, the prevalence of ITPD 0% was 
significantly higher in vessels with CAC score <300 as compared to vessels with a CAC score 
≥300 (65% versus 43%, respectively, P<0.001). Differently, the prevalence of ITPD <5% was 
significantly higher in vessels with CAC score ≥300 as compared to those with CAC score 
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<300, (46% versus 26%, respectively, P<0.05), while no differences between the two groups 
were observed in the presence of ITPD ≥5%.  
Relation between CAC score, regional ITPD and coronary vascular function 
ROC analysis identified a CFR of 1.64 as the best cut-off value in identifying obstructive 
CAD (Figure 1). Reduced CFR was observed in 79 (28%) of the overall 244 vessels. The 
prevalence of reduced CFR according to CAC score and ITPD categories is depicted in Figure 
2. The prevalence of reduced CFR is not significantly different between vessels with CAC 
score <300 and those with CAC score ≥300 in all ITPD categories. Moreover, the number of 
vessels with reduced CFR significantly increases with the increase of ITPD categories (24% 
32% and 50%, respectively, P<0.05). 
Prevalence of obstructive CAD across different CAC score, ITPD and CFR categories 
The prevalence of obstructive CAD across different CAC score, ITPD and CFR categories is 
showed in Figure 3. As illustrated, in vessels with a CAC score<300 the prevalence of 
obstructive CAD was significantly higher in the presence of reduced CFR in both ITPD 
categories 0% and <5% (P <0.001 and P<0.05, respectively). On the contrary, in vessels with 
CAC score ≥300, the prevalence of obstructive CAD was comparable between the different 
ITPD and CFR categories. 
Univariable and multivariable analyses 
Univariable and multivariable logistic regression analyses in predicting obstructive CAD are 
reported in Table 3. At univariable analysis, age (P<0.001), male gender (P<0.01), a CAC 
score ≥ 300 (P<0.01), regional ITPD (P <0.001) and regional CFR<1.64 (P <0.001) were 
significant predictors of obstructive CAD. At multivariable analysis CAC score ≥300 (P 
<0.05), regional ITPD (P <0.001) and regional CFR <1.64 (P <0.001) resulted independent 
predictors of obstructive CAD. Incremental analysis results are reported in Figure 4. The 
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addition of regional ITPD to a model including clinical variables (age, male gender, diabetes, 
hypertension, dyslipidemia, smoking, family history) and a CAC score ≥300 increased the 
global chi-square value in predicting obstructive CAD from 29.91 to 72.72 (P <0.001). 
Moreover, the addition of regional CFR<1.64, to a model including clinical data, CAC score 
and regional ITPD, further significantly increased the global chi-square from 72.72 to 91.97 
(P <0.001). The continuous NRI by adding regional CFR to clinical data was 0.682 (95% 
bootstrap confidence interval 0.274-1.045). 
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Discussion 
To our knowledge, this is the first study examining the regional interaction between CAC 
score, myocardial ischemia and quantitative CFR in the identification of obstructive CAD on 
coronary angiography. From this study, it emerged that in patients with suspected CAD, the 
addition of regional CFR to clinical data, CAC score and ITPD could be helpful to identify 
the presence of obstructive CAD. 
82Rb PET/CT imaging is being increasingly used for the evaluation of selected patients with 
known or suspected CAD [16]. The vast majority of PET-MPI studies are performed with 
PET/CT systems with which CAC scanning can be estimated with reasonable accuracy from 
the attenuation scans routinely performed for the PET [17]. Indeed, both CAC scoring and 
myocardial perfusion evaluation are used for risk stratification in patients with suspected 
CAD combining anatomic and functional data [18]. Schepis et al. [19] investigated the added 
value of the CAC score as an adjunct to MPI findings for the assessment of CAD in 77 
patients at intermediate risk using single photon emission computed tomography (SPECT) 
imaging. Higher global CAC score values were observed in subjects with abnormal SPECT 
results and in patients with significant CAD (≥50% stenosis) at coronary angiography. 
However, considering that clinically CAD presents as a continuous spectrum of severity, 
absolute measures of MBF and CFR obtained by PET imaging besides the evaluation of 
myocardial ischemia can offer a unique advantage in assessing the extent of CAD. Previous 
studies evaluated the effects of coronary atherosclerosis morphology and extent on CFR [20-
22]. Yoshinaga et al. [20]. evaluated regional MBF in segments with and without ischemia 
using 82Rb PET in a small (n=12) cohort of patients with CAD. These authors found a 
significant inverse correlation between MBF and CFR measurements with significant 
diameter stenosis on coronary angiography in vessels with and without ischemia. Moreover, 
in a study of 73 patients, including 19 patients with 3-vessel CAD, Fiechter et al. [21] 
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demonstrated that a reduced CFR (<2.0), obtained by 13N-ammonia PET-CT imaging, was 
associated with a much higher positive predictive value for identifying extensive CAD on 
angiography. Naya et. al [22] evaluated the relationship between atherosclerosis plaque 
burden, morphology, and composition and regional CFR in 73 consecutive patients 
undergoing 82Rb PET and coronary computed tomography angiography (CTA) for the 
evaluation of known or suspected CAD. They found that, on a per-patient analysis, global 
quantitative estimates of CFR were sensitive markers for the identification of patients with 
high-risk anatomic disease by CTA. In a more recent report, the same authors [6] evaluated 
how a preserved CFR could be helpful in excluding high risk CAD at coronary angiography 
in 180 patients. These authors identified the best cut-off for CFR for the detection of 
multivessels disease using ROC curve analysis (CFR <1.93), Their results showed that a 
normal CFR had a high negative predictive value for excluding high-risk CAD on 
angiography. Moreover, although an abnormal CFR increases the probability of significant 
obstructive CAD, the authors concluded that it cannot reliably distinguish significant from 
nonobstructive epicardial stenosis, diffuse atherosclerosis or microvascular dysfunction. More 
recently, Brodov and colleagues [8] in 152 consecutive patients without history of CAD 
showed how the combination of regional analysis of both CAC score and ITPD improves 
diagnostic accuracy of 82Rb PET-CT imaging in detecting CAD. However, despite the use of 
PET-CT in combining anatomic and functional information, no data has been presented on the 
possible role of regional CFR in the evaluation of ostructive CAD.  In our study for the first 
time a combination of regional measures of CAC score, ITPD and CFR were considered in a 
relatively high cohort of patients with suspected CAD. From our analysis, a regional CFR 
<1.64 resulted the best cut-off value in order to identify the presence of severe CAD. As 
already showed by previous report [5,6], different severity threshold for CFR may be 
considered, according to the wide variability related to subclinical and clinical condition, 
different radionuclides, scanners, imaging protocols, stress agents and flow models. 
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Interestingly, on a per-vessels analysis, we found a higher prevalence of obstructive CAD in 
vessels with reduced CFR.  In particular, the prevalence of severe CAD was significantly 
higher in vessels with low CAC score in the presence of a reduced CFR, both in non-ischemic 
vessels and in those with mild-moderate ischemia. Differently, no significant differences were 
appreciated in vessels with high CAC score values among all ITPD groups. This data should 
be potentially explained by the evidence that diffuse atherosclerosis or microvascular 
dysfunction could affect CFR measurements also in patients without significant stenosis. In 
particular, since high CAC score is associated with coronary vascular dysfunction and 
reduced CFR [23], in vessels with lower CAC score values a significant decrease in CFR may 
reflect the presence of non-calcified obstructive plaque. Our results support the additive value 
of regional measurements of ITPD and CFR in identifying obstructive CAD. At incremental 
analysis, the addition of regional ITPD to a model including clinical data and CAC score, 
improve the power of the model in predicting obstructive CAD. Moreover, in our study the 
addition of regional CFR to a model including clinical data, CAC score and regional ITPD 
further ìncrease the global chisquare in detecting severe CAD, with a continues NRI of 0.68.  
Conclusion 
The prevalence of obstructive CAD is higher in the presence of reduced CFR, in particular in 
patients with CAC score <300 and absent or mild-moderate ischemia.  At per vessels analysis 
CAC score, ITPD and CFR result independent predictors of obstructive CAD. However, 
addition of regional CFR to a model including clinical data, CAC score and ITPD has an 
incremental value in the identification of obstructive CAD in patients with suspected CAD.  
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Table 1. Patients characteristics 
 All  Obstructive CAD Non-obstructive CAD  
 (n=93) (n=36) (n=57) P value 
Age 59±11 63±10 57±12 .042 
Male gender 73(78%) 33(92%) 40(70%) .014 
Diabetes 24(26%) 12(33%) 12(21%) .187 
Hypertension 84(90%) 32(89%) 52(91%) .710 
Dyslipidemia 72(77%) 29(80%) 43(75%) .565 
Smoking history 44(47%) 18(50%) 26(46%) .680 
Family history of CAD 52(56%) 18(50%) 34(60%) .361 
Angina  20(21%) 4(11%) 16(28%) .053 
Values are expressed as mean value±standard deviation or as number (percentage) ofsubjects 
CAD coronary artery disease. 
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Table 2. Coronary calcium and myocardial perfusion findings in per-vessel analysis 
 All  Obstructive CAD Non-obstructive CAD  
 (n=279) (n=54) (n=225) P value 
CAC score      
<300 244 (87%) 41 (76%) 203 (90%) <.05 
≥300 35 (13%) 13(24%) 22 (10%) <.05 
Baseline MBF 0.80±0.3 0.67±0.2 0.82±0.3 <.01 
Hyperemic MBF 1.52±0.6 1.10±0.5* 1.63±0.6* <.001 
CFR 2.14±0.8 1.66±0.6 2.24±0.7 <.001 
ITPD 1.54±3.7 5.1±6 0.7±1 <.001 
 
Values are expressed as mean value±standard deviation, *P<0.001 versus baseline MBF 
MBF myocardial blood flow;CFRcoronary flow reserve; ITPD ischemic total perfusion defect 
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Table 3. Univariable and multivariable predictors of obstructive CAD 
 Univariable analysis Multivariable analysis 
 Odds Ratio (C.I. 95%) P value Odds Ratio (C.I. 95%) P value 
Age 1.055 (1.024-1.087) <.001 1.016 (0.977-1.057) .432 
Male gender 5.768 (1.733-19.198) <.01 1.7281 (0.455-6.559) .421 
Diabetes 1.583 (0832-3.012) .161   
Hypertension 1.062 (0.383-2.945) .908   
Dyslipidemia 0.705 (0.359-1.386) .311   
Smoking history 0.951 (0.524-1.724) .868   
Family history of CAD 0.619 (0.341-1.124) .115   
CAC score ≥300 2.926 (1.364-6.277) <.01 2.854 (1.084-7.513) <.05 
ITPD 0% (Reference group)     
ITPD <5% 5.087 (2.415-10.714) <.001 4.068 (1.756-9.425) <.005 
ITPD ≥5% 27.865 (10.185-76.237) <.001 24.469 (7.863-76.142) <.001 
CFR<1.64 6.115 (3.238-11.549) <.001 5.583 (2.470-12.617) <.001 
CAD coronary artery disease; CFR coronary flow reserve; ITPD ischemic total perfusion 
defect 
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Figure 1. Prevalence of ITPD categories (0%, <5% and ≥ 5%) in per vessels analysis 
according to CAC score categories <300 (A)  and ≥ 300 (B) 
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Figure 2: Univariate receiver operating characteristic (ROC) curve showing sensitivity (blue 
curve) and specificity (red curve) pairs for identification of patients with obstructive CAD by 
use regional CFR 
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Figure 3. Prevalence of reduced CFR (<1.64) according to ITPD (0%; <5%, ≥5%) and CAC 
score (<300, ≥300) categories 
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Figure 4. Prevalence of obstructive CAD across different CAC score (<300, ≥300), ITPD 
(0%; <5%, ≥5%) and CFR (≥1.64; <1.64) categories 
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Figure 5. Incremental value of regional CFR (<1.64) in predicting obstructive CAD 
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